Management of Atrial Fibrillation with Rapid Ventricular Response
Pathophysiology and Concerns
- Dopamine causes vasoconstriction by releasing norepinephrine from sympathetic vesicles and acting directly on alpha-adrenergic receptors, which can exacerbate rapid ventricular response in atrial fibrillation 1
- In elevated catecholamine states, beta blockers are the preferred agents, not dopamine, as recommended by the American College of Cardiology 2
Recommended Management for AFib with Rapid Ventricular Response
For Hemodynamically Unstable Patients:
- Prompt direct-current cardioversion is the first-line treatment for hemodynamically compromised patients, as recommended by the American College of Cardiology 3, 2
- Synchronized cardioversion is highly effective in terminating atrial fibrillation and should be considered early in management of unstable patients, according to the American Heart Association 4, 5
For Hemodynamically Stable Patients:
- Rate control using beta blockers or calcium channel blockers is the recommended first-line approach, as suggested by the American College of Cardiology 3, 2
- Beta blockers are particularly beneficial when there is an elevated catecholamine state, as recommended by the American College of Cardiology 2
Special Considerations
- In patients with pre-excitation syndrome (WPW) with atrial fibrillation, avoid AV nodal blocking agents, as they may enhance conduction over accessory pathways, according to the American Heart Association 5, 6, 7
- Intravenous procainamide or ibutilide is recommended to restore sinus rhythm or slow ventricular rate in patients with WPW, as suggested by the American College of Cardiology 2
- Catheter ablation of the accessory pathway is recommended for symptomatic patients with WPW, as recommended by the American College of Cardiology 2
- For patients with chronic obstructive pulmonary disease, treatment of underlying lung disease and correction of hypoxia and acid-base imbalance are primary concerns, as recommended by the American College of Cardiology 2
- Non-beta-1-selective blockers should be avoided in patients with bronchospasm, according to the American College of Cardiology 2
Common Pitfalls to Avoid
- In patients with WPW syndrome and pre-excited AF, administration of AV nodal blockers can be potentially harmful by accelerating the ventricular rate, as warned by the American College of Cardiology 2
- Recognize that antiarrhythmic drug therapy may be ineffective until any underlying respiratory decompensation has been corrected, as noted by the American College of Cardiology 2